NAV

Fusarium graminearum

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Summary

Fusarium graminearum is an extract from Fusarium graminearum used in allergy testing.

Generic Name
Fusarium graminearum
DrugBank Accession Number
DB13907
Background

Fusarium graminearum allergenic extract is used in allergenic testing.

Type
Biotech
Groups
Approved, Experimental
Biologic Classification
Allergenics
Allergen Extract
Synonyms
  • Botryosphaeria saubinetii
  • Dichomera saubinetii
  • Dothidea zeae
  • Fusarium graminearum
  • Fusarium roseum
  • Gibbera saubinetii
  • Gibberella rosea
  • Gibberella saubinetii
  • Gibberella zeae
  • Gibberella zeae whole
  • Sphaeria saubinetii
  • Sphaeria zeae
Poor quality drug data slowing you down?
Unlock 38% more drug discovery time and eliminate decision-making doubts with this one-stop guide to quality drug data.
Download eBook
Poor quality drug data slowing you down?
Download eBook

Pharmacology

Indication

Not Available

Reduce drug development failure rates
Build, train, & validate machine-learning models
with evidence-based and structured datasets.
See how
Build, train, & validate predictive machine-learning models with structured datasets.
See how
Contraindications & Blackbox Warnings
Prevent Adverse Drug Events Today
Tap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.
Learn more
Avoid life-threatening adverse drug events with our Clinical API
Learn more
Pharmacodynamics

Not Available

Mechanism of action
Not Available
Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism
Not Available
Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects
Improve decision support & research outcomes
With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!
See the data
Improve decision support & research outcomes with our structured adverse effects data.
See a data sample
Toxicity

Not Available

Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions
Not Available

Products

Drug product information from 10+ global regions
Our datasets provide approved product information including:
dosage, form, labeller, route of administration, and marketing period.
Access now
Access drug product information from over 10 global regions.
Access now
Brand Name Prescription Products
NameDosageStrengthRouteLabellerMarketing StartMarketing EndRegionImage
Gibberella PulicarisInjection, solution0.05 g/1mLPercutaneousALK-Abello, Inc.1965-01-01Not applicableUS flag
Gibberella PulicarisInjection, solution0.1 g/1mLSubcutaneousALK-Abello, Inc.1965-01-01Not applicableUS flag
Mixture Products
NameIngredientsDosageRouteLabellerMarketing StartMarketing EndRegionImage
Fapp MixtureFusarium graminearum (20000 [PNU]/1mL) + Aspergillus niger var. niger (20000 [PNU]/1mL) + Aspergillus oryzae (20000 [PNU]/1mL) + Aspergillus repens (20000 [PNU]/1mL) + Aspergillus terreus (20000 [PNU]/1mL) + Penicillium chrysogenum var. chrysogenum (20000 [PNU]/1mL) + Phoma exigua var. exigua (20000 [PNU]/1mL)Injection, solutionSubcutaneousALK-Abello, Inc.1965-01-012023-05-24US flag
Midwest MoldsFusarium graminearum (20000 [PNU]/1mL) + Chaetomium globosum (20000 [PNU]/1mL) + Cochliobolus sativus (20000 [PNU]/1mL) + Mucor plumbeus (20000 [PNU]/1mL) + Phoma exigua var. exigua (20000 [PNU]/1mL) + Rhizopus arrhizus var. arrhizus (20000 [PNU]/1mL)Injection, solutionSubcutaneousALK-Abello, Inc.1965-01-012023-05-24US flag
Mold Mix 2Fusarium graminearum (40000 [PNU]/1mL) + Aureobasidium pullulans var. pullutans (40000 [PNU]/1mL) + Curvularia inaequalis (40000 [PNU]/1mL) + Mucor plumbeus (40000 [PNU]/1mL) + Rhizopus arrhizus var. arrhizus (40000 [PNU]/1mL)Injection, solutionSubcutaneousALK-Abello, Inc.1965-01-012023-05-24US flag
Mold Mix 2Fusarium graminearum (20000 [PNU]/1mL) + Aureobasidium pullulans var. pullutans (20000 [PNU]/1mL) + Curvularia inaequalis (20000 [PNU]/1mL) + Mucor plumbeus (20000 [PNU]/1mL) + Rhizopus arrhizus var. arrhizus (20000 [PNU]/1mL)Injection, solutionSubcutaneousALK-Abello, Inc.1965-01-012023-05-24US flag
Mold Mix 2Fusarium graminearum (0.1 g/1mL) + Aureobasidium pullulans var. pullutans (0.1 g/1mL) + Curvularia inaequalis (0.1 g/1mL) + Mucor plumbeus (0.1 g/1mL) + Rhizopus arrhizus var. arrhizus (0.1 g/1mL)Injection, solutionPercutaneousALK-Abello, Inc.1998-02-232023-05-24US flag

Categories

Drug Categories
Classification
Not classified
Affected organisms
Not Available

Chemical Identifiers

UNII
T9GHE8H4RX
CAS number
Not Available

References

General References
Not Available
RxNav
1922751
Wikipedia
Fusarium_graminearum

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
FormRouteStrength
Injection, solutionPercutaneous0.05 g/1mL
Injection, solutionSubcutaneous0.1 g/1mL
Injection, solutionPercutaneous
Injection, solutionPercutaneous; Subcutaneous
Injection, solutionSubcutaneous
Prices
Not Available
Patents
Not Available

Properties

State
Solid
Experimental Properties
Not Available

Drug created at September 08, 2017 21:36 / Updated at June 12, 2020 16:53